|Peakdale Science Park
Tel: +44 1298 816700
Fax: +44 1298 816701
Peakdale Molecular has launched a new range of targeted Peakexplorer™ libraries with the first focused on GPCR research.
These novel, drug like compounds have been designed by combining pharmacophore modelling algorithms developed by De Novo Pharmaceuticals with Peakdale’s proprietary chemistry and parallel synthesis capabilities.
Please visit www.peakexplorer.com to learn more.
Peakdale Molecular Limited (UK) provides drug discovery support services and research chemicals to the pharmaceutical and life-science industries. Peakdale has earned its world-class reputation as an innovative chemistry provider by designing, producing and supplying novel compounds that prove to be highly useful in pharmaceutical research programs.
Peakdale's business has been built around its unique chemistry skills and experience in custom synthesis. By using novel chemical synthetic approaches alongside classical methodologies, a reputation for completing even the most challenging syntheses has been earned. Facilities include scale up laboratory reactors - up to 50 litre jacketed vessels giving an effective temperature range of -40°C to 180°C
Further Information: http://www.peakdale.co.uk/
Peakdale Introduces peakfinder™ Chemogenetic Kinase Arrays
Peakfinder chemogenetic arrays enhance receptor-ligand interactions within different but closely related families of targets.
Related news from our archive
Peakdale Molecular Expands its Capacity and Capabilities
The addition of facilities and equipment has increased Peakdale’s range for large-scale processes and ability to perform synthesis techniques including low-temperature and microwave chemistry.
Peakdale Extends its Range of Medicinal Chemistry Services
The services enable the Company to provide compounds with a starting point for hit discovery.